Zionsville, IN, United States of America

Matthew David Backfish

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Matthew David Backfish

Introduction

Matthew David Backfish is an accomplished inventor based in Zionsville, IN (US). He has made significant contributions to the field of medication delivery devices, holding a total of 2 patents. His work focuses on improving the efficiency and usability of therapeutic agent delivery systems.

Latest Patents

Matthew's latest patents include a medication delivery device that features both disposable and reusable portions. The device is designed to enhance the delivery of therapeutic agents through a needle. The disposable portion contains a therapeutic agent delivery assembly that can transition from a stowed configuration to a deployed configuration. The reusable portion incorporates a first and second rack and pinion mechanism, which are actuatable to facilitate the translation of the therapeutic agent delivery assembly and the plunger, respectively. This innovative design aims to streamline the process of medication delivery, making it more effective for users.

Career Highlights

Matthew David Backfish is currently employed at Eli Lilly and Company, a leading pharmaceutical company known for its commitment to innovation in healthcare. His role at Eli Lilly allows him to work on cutting-edge projects that aim to improve patient outcomes through advanced medical technologies.

Collaborations

Matthew collaborates with talented professionals in his field, including his coworker Murat Günay. Together, they contribute to the development of innovative solutions in medication delivery.

Conclusion

Matthew David Backfish's contributions to the field of medication delivery devices exemplify his dedication to innovation and improving healthcare solutions. His patents reflect a commitment to enhancing the efficiency of therapeutic agent delivery systems, ultimately benefiting patients and healthcare providers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…